143 related articles for article (PubMed ID: 3158760)
1. [Adult T-cell leukemia with OKT4 and OKT8 subsets].
Natori H; Egami K; Tanaka K; Nakamura E; Natori K; Kaji M; Okubo K; Matsuo Y; Chiba S; Ishii N
Rinsho Ketsueki; 1985 Jan; 26(1):52-7. PubMed ID: 3158760
[No Abstract] [Full Text] [Related]
2. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
3. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
[TBL] [Abstract][Full Text] [Related]
5. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
[TBL] [Abstract][Full Text] [Related]
6. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
Perl A; Gonzalez-Cabello R; Gergely P
J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of T cell subsets with monoclonal antibodies in synovial fluid in rheumatoid arthritis.
Veys EM; Hermanns P; Verbruggen G; Schindler J; Goldstein G
J Rheumatol; 1982; 9(6):821-6. PubMed ID: 6219220
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte subsets in primary and secondary glomerulonephritis.
Fornasieri A; Sinico R; Fiorini G; Goldaniga D; Colasanti G; Vendemia F; Gibelli A; D'Amico G
Proc Eur Dial Transplant Assoc; 1983; 19():635-41. PubMed ID: 6224213
[TBL] [Abstract][Full Text] [Related]
9. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.
Kotani H; Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
Clin Exp Immunol; 1984 May; 56(2):390-8. PubMed ID: 6234113
[TBL] [Abstract][Full Text] [Related]
10. Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinaemia.
Pandolfi F; Corte G; Quinti I; Fiorilli M; Frieligsdorf A; Bargellesi A; Aiuti F
Clin Exp Immunol; 1983 Mar; 51(3):470-4. PubMed ID: 6221843
[TBL] [Abstract][Full Text] [Related]
11. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
[TBL] [Abstract][Full Text] [Related]
12. [Lichen planus. Study of the T-lymphocyte population and Langerhans cells using monoclonal antibodies].
Fernández Bussy RA; Schmitt D; Mauduit G; Gomes MA; Thivolet J
Med Cutan Ibero Lat Am; 1983; 11(1):17-22. PubMed ID: 6224058
[TBL] [Abstract][Full Text] [Related]
13. Enumeration of T lymphocytes subsets in autoimmune disease using monoclonal antibodies.
Raeman F; De Cock W; De Beukelaar T; De Cree J; Verhaegen H
Clin Exp Immunol; 1981 Sep; 45(3):475-9. PubMed ID: 6461446
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides. Peripheral T cell subsets defined by specific monoclonal antibodies.
Valsecchi R; Reseghetti A; Bontempelli M; Frigeni A; Cainelli T
Dermatologica; 1984; 169(1):12-7. PubMed ID: 6236114
[TBL] [Abstract][Full Text] [Related]
15. [Application of T-cell subset monoclonal antibody in the immunologic assay of cancer patients].
Xu LX
Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):99-102. PubMed ID: 3159558
[No Abstract] [Full Text] [Related]
16. T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.
Bernengo MG; Lisa F; Puiatti P; Meregalli M; Berruto G; Zina G
Thymus; 1983 Apr; 5(3-4):223-33. PubMed ID: 6224319
[TBL] [Abstract][Full Text] [Related]
17. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
Buechner SA; Winkelmann RK; Banks PM
Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293
[TBL] [Abstract][Full Text] [Related]
18. Recognition of immature T-cell phenotypes in neonatal blood using monoclonal antibodies.
Patterson JA; Griffiths-Chu S; Berger CL; Edelson RL; Chu AC
Diagn Immunol; 1983; 1(3):205-10. PubMed ID: 6238751
[TBL] [Abstract][Full Text] [Related]
19. Do anti-T4 (Leu 3) and anti-T8 (Leu 2) monoclonal antibodies delineate T-cell subsets with helper/inducer and suppressor/cytotoxic function, respectively?
Ceuppens J
Thymus; 1983 Sep; 5(5-6):445-6. PubMed ID: 6229066
[No Abstract] [Full Text] [Related]
20. Lymphocyte subsets in endometriosis.
Gleicher N; Dmowski WP; Siegel I; Liu TL; Friberg J; Radwanska E; Toder V
Obstet Gynecol; 1984 Apr; 63(4):463-6. PubMed ID: 6230549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
